Woodline Partners LP

Position in IMNM — Immunome Inc.

CIK 1784547 San Francisco, CA

Position in IMNM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,198,433

-$13,255,521 QoQ

Shares Held

1,000,398

-36.5% QoQ

Ownership

0.881%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#22

of 200 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. IMNM ranks #58 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,198,433	1,000,398	-36.5%	Shares	Sole	2026-08-14
2026-03-31	$34,453,954	1,575,398	0.0%	Shares	Sole	2026-05-15
2025-12-31	$33,839,549	1,575,398	+23.6%	Shares	Sole	2026-02-17
2025-09-30	$14,927,076	1,274,729	-23.1%	Shares	Sole	2025-11-14
2025-06-30	$15,425,565	1,658,663	+0.1%	Shares	Sole	2025-08-14
2025-03-31	$11,156,516	1,657,729	+69.0%	Shares	Sole	2025-05-15
2024-12-31	$10,417,423	980,925	+6.1%	Shares	Sole	2025-02-14
2024-09-30	$13,514,611	924,392	+0.2%	Shares	Sole	2024-11-14
2024-06-30	$11,166,993	922,892	-30.0%	Shares	Sole	2024-08-14
2024-03-31	$32,529,622	1,318,056	+42.8%	Shares	Sole	2024-05-15
2023-12-31	$9,874,944	922,892	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.